Gold Bear Market Hits NEM: Thesis Under Pressure as Macro Tailwind Reverses

What happened

Gold has entered its first bear market since 2022, slumping more than 20% from its peak. For Newmont, the world's largest gold producer, this is a critical blow because the entire investment thesis—record free cash flow, aggressive buybacks, and a $120+ stock price—rests on sustained elevated gold prices. Q1 2026's $3.1B free cash flow was a product of gold averaging $4,900/oz; a prolonged bear market would compress margins, push AISC above guided levels, and threaten capital return programs. The DeepValue report already flagged a WAIT rating with attractive entry at $110, but this macro shock accelerates downside risks, especially if Q2 unit costs rise as management guided. The Nevada Gold Mines dispute and H2-weighted production add further fragility. Investors should brace for a period of volatility and reassess whether the bull-case assumptions are still valid.

Implication

The bear market destroys the core pillar of Newmont's bull case: persistent high gold prices. While the company has a strong balance sheet ($8.8B cash), the stock's premium (15.5x P/E) was built on record earnings that are now at risk. Investors must monitor (1) gold price stabilization, (2) Q2 AISC relative to guidance ($1,680/oz), and (3) any changes to the buyback pace. If gold stays below $3,800/oz, NEM could test the $105 bear-case target. A re-assessment window of 3–6 months is appropriate; a pullback toward $110 might offer a margin of safety, but only if gold recovers. Avoid adding until the macro and cost picture clarifies.

Thesis delta

The gold bear market shifts the probability weight toward the bear case (25% → 35%+), where AISC exceeds $1,850/oz and free cash flow falls below $1.0B per quarter. The base-case assumption of 'gold prices stay elevated enough to offset cost step-ups' is now directly challenged. The bull case—sustained aggressive buybacks driven by $2B+ quarterly FCF—becomes far less probable. This changes the call from 'wait for cost data' to 'wait for price recovery and cost confirmation.' The attractive entry of $110 may become a reality sooner than expected, but buying now offers no margin of safety given the negative macro.